Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors.
Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) signal through EGF and PDGF receptors, which are important receptor tyrosine kinases (RTKs). Growth hormone (GH) and prolactin (PRL) are four helical bundle peptide hormones that signal via GHR and PRLR, members of the cytokine receptor superfamily. In this study, we examine crosstalk between signaling pathways emanating from these disparate receptor groups (RTKs and cytokine receptors). We find that GH and EGF specifically synergize for activation of ERK in murine preadipocytes. The locus of this synergy resides at the level of MEK activation, but not above this level (i.e., not at the level of EGFR, SHC, or Raf activation). Furthermore, dephosphorylation of the scaffold protein, KSR, at a critical serine residue is also synergistically promoted by GH and EGF, suggesting that GH sensitizes these cells to EGF-induced ERK activation by augmenting the actions of KSR in facilitating MEK-ERK activation. Similarly specific synergy in ERK activation is also detected in human T47D breast cancer cells by cotreatment with PRL and PDGF. This synergy also resides at the level of MEK activation. Consistent with this synergy, PRL and PDGF also synergized for c-fos-dependent transactivation of a luciferase reporter gene in T47D cells, indicating that events downstream of ERK activation reflect this signaling synergy. Important conceptual and physiological implications of these findings are discussed.
Li
Xin
X
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294-0012, USA.
Huang
Yao
Y
Jiang
Jing
J
Frank
Stuart J
SJ
D016475:3T3 Cells; D000818:Animals; D002478:Cells, Cultured; D004789:Enzyme Activation; D004815:Epidermal Growth Factor / Q000494:pharmacology / Q000502:physiology; D066246:ErbB Receptors / Q000819:agonists / Q000502:physiology*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D017930:Genes, Reporter; D019382:Human Growth Hormone / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D051379:Mice; D051966:Phospholipase C gamma / Q000378:metabolism; D010766:Phosphorylation; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology / Q000502:physiology; D011388:Prolactin / Q000494:pharmacology / Q000502:physiology; D011494:Protein Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D020239:Receptor Cross-Talk; D017479:Receptors, Platelet-Derived Growth Factor / Q000819:agonists / Q000502:physiology*; D011981:Receptors, Prolactin / Q000819:agonists / Q000502:physiology*; D011986:Receptors, Somatotropin / Q000819:agonists / Q000502:physiology*; D015398:Signal Transduction
D010982:Platelet-Derived Growth Factor; D011981:Receptors, Prolactin; D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; D004815:Epidermal Growth Factor; D011388:Prolactin; D011494:Protein Kinases; C097199:KSR-1 protein kinase; D066246:ErbB Receptors; D017479:Receptors, Platelet-Derived Growth Factor; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases; D051966:Phospholipase C gamma